• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于呼吸道给药的多糖聚电解质复合物的生物相容性和稳定性

Biocompatibility and Stability of Polysaccharide Polyelectrolyte Complexes Aimed at Respiratory Delivery.

作者信息

Rodrigues Susana, Cardoso Lurdes, da Costa Ana M Rosa, Grenha Ana

机构信息

CBMR-Centre for Biomedical Research, University of Algarve, Faculty of Sciences and Technology, Campus de Gambelas, Faro 8005-139, Portugal.

CIQA-Algarve Chemistry Research Centre and Department of Chemistry and Pharmacy, Faculty of Sciences and Technology, University of Algarve, Campus de Gambelas, Faro 8005-139, Portugal.

出版信息

Materials (Basel). 2015 Aug 28;8(9):5647-5670. doi: 10.3390/ma8095268.

DOI:10.3390/ma8095268
PMID:28793528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5512620/
Abstract

Chitosan (CS) and chondroitin sulfate (CHS) are natural polymers with demonstrated applicability in drug delivery, while nanoparticles are one of the most explored carriers for transmucosal delivery of biopharmaceuticals. In this work we have prepared CS/CHS nanoparticles and associated for the first time the therapeutic protein insulin. Fluorescein isothiocyanate bovine serum albumin (FITC-BSA) was also used to enable comparison of behaviors regarding differences in molecular weight (5.7 kDa 67 kDa). Nanoparticles of approximately 200 nm and positive zeta potential around +20 mV were obtained. These parameters remained stable for up to 1 month at 4 °C. Proteins were associated with efficiencies of more than 50%. The release of FITC-BSA in PBS pH 7.4 was more sustained (50% in 24 h) than that of insulin (85% in 24 h). The biocompatibility of nanoparticles was tested in Calu-3 and A549 cells by means of three different assays. The metabolic assay MTT, the determination of lactate dehydrogenase release, and the quantification of the inflammatory response generated by cell exposure to nanoparticles have indicated an absence of overt toxicity. Overall, the results suggest good indications on the application of CS/CHS nanoparticles in respiratory transmucosal protein delivery, but the set of assays should be widened to clarify obtained results.

摘要

壳聚糖(CS)和硫酸软骨素(CHS)是天然聚合物,在药物递送方面已显示出适用性,而纳米颗粒是生物药物经粘膜递送研究最多的载体之一。在这项工作中,我们制备了CS/CHS纳米颗粒,并首次将治疗性蛋白质胰岛素与之结合。还使用了异硫氰酸荧光素牛血清白蛋白(FITC-BSA)来比较分子量差异(5.7 kDa对67 kDa)下的行为。获得了直径约200 nm、zeta电位为+20 mV左右的纳米颗粒。这些参数在4°C下可稳定长达1个月。蛋白质结合效率超过50%。FITC-BSA在pH 7.4的磷酸盐缓冲盐溶液(PBS)中的释放比胰岛素更持久(24小时内释放50%,而胰岛素为85%)。通过三种不同的测定方法在Calu-3和A549细胞中测试了纳米颗粒的生物相容性。代谢测定MTT、乳酸脱氢酶释放的测定以及细胞暴露于纳米颗粒产生的炎症反应的定量表明没有明显毒性。总体而言,结果表明CS/CHS纳米颗粒在呼吸道经粘膜蛋白质递送中的应用有良好前景,但应扩大测定方法的范围以阐明所得结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efad/5512620/35162c5a5007/materials-08-05268-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efad/5512620/5d88bf34c33b/materials-08-05268-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efad/5512620/5ccf54d23130/materials-08-05268-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efad/5512620/8496dcc75905/materials-08-05268-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efad/5512620/c4cdc0d0cef9/materials-08-05268-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efad/5512620/788a2d9d4d20/materials-08-05268-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efad/5512620/ea73e9704219/materials-08-05268-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efad/5512620/35162c5a5007/materials-08-05268-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efad/5512620/5d88bf34c33b/materials-08-05268-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efad/5512620/5ccf54d23130/materials-08-05268-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efad/5512620/8496dcc75905/materials-08-05268-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efad/5512620/c4cdc0d0cef9/materials-08-05268-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efad/5512620/788a2d9d4d20/materials-08-05268-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efad/5512620/ea73e9704219/materials-08-05268-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efad/5512620/35162c5a5007/materials-08-05268-g007.jpg

相似文献

1
Biocompatibility and Stability of Polysaccharide Polyelectrolyte Complexes Aimed at Respiratory Delivery.用于呼吸道给药的多糖聚电解质复合物的生物相容性和稳定性
Materials (Basel). 2015 Aug 28;8(9):5647-5670. doi: 10.3390/ma8095268.
2
Influence of charge on FITC-BSA-loaded chondroitin sulfate-chitosan nanoparticles upon cell uptake in human Caco-2 cell monolayers.载 FITC-BSA 的硫酸软骨素-壳聚糖纳米粒荷电性对人 Caco-2 细胞单层细胞摄取的影响。
Int J Nanomedicine. 2012;7:4861-72. doi: 10.2147/IJN.S34770. Epub 2012 Aug 10.
3
Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization.新型载蛋白硫酸软骨素-壳聚糖纳米粒的制备与表征。
Acta Biomater. 2011 Oct;7(10):3804-12. doi: 10.1016/j.actbio.2011.06.026. Epub 2011 Jun 24.
4
Pullulan-based nanoparticles as carriers for transmucosal protein delivery.基于支链淀粉的纳米粒作为黏膜下蛋白递药载体。
Eur J Pharm Sci. 2013 Sep 27;50(1):102-13. doi: 10.1016/j.ejps.2013.04.018. Epub 2013 Apr 25.
5
Hybrid nanosystems based on natural polymers as protein carriers for respiratory delivery: Stability and toxicological evaluation.基于天然聚合物的杂交纳米系统作为呼吸递药的蛋白质载体:稳定性和毒理学评价。
Carbohydr Polym. 2015 Jun 5;123:369-80. doi: 10.1016/j.carbpol.2015.01.048. Epub 2015 Feb 3.
6
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.低分子量壳聚糖纳米颗粒作为小鼠鼻腔疫苗递送的新型载体
Eur J Pharm Biopharm. 2004 Jan;57(1):123-31. doi: 10.1016/j.ejpb.2003.09.006.
7
Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery.壳聚糖和酰化油菜籽芸苔球蛋白的聚电解质复合纳米粒子用于姜黄素传递。
J Agric Food Chem. 2018 Mar 21;66(11):2685-2693. doi: 10.1021/acs.jafc.7b05083. Epub 2018 Feb 27.
8
Characterization of polyelectrolyte complexes between chondroitin sulfate and chitosan in the solid state.固态下硫酸软骨素与壳聚糖之间聚电解质复合物的表征
J Biomed Mater Res A. 2005 Oct 1;75(1):128-37. doi: 10.1002/jbm.a.30393.
9
Preparation and characterization of polyelectrolyte complex nanoparticles based on poly (malic acid), chitosan. A pH-dependent delivery system.基于聚(苹果酸)、壳聚糖的聚电解质复合纳米颗粒的制备与表征。一种pH依赖性递送系统。
J Biomater Sci Polym Ed. 2017 Jan;28(1):50-62. doi: 10.1080/09205063.2016.1242460. Epub 2016 Oct 13.
10
Methylated N-(4-N,N-dimethylaminobenzyl) chitosan coated liposomes for oral protein drug delivery.甲基化 N-(4-N,N-二甲基氨基苄基)壳聚糖包覆的脂质体用于口服蛋白药物传递。
Eur J Pharm Sci. 2012 Sep 29;47(2):359-66. doi: 10.1016/j.ejps.2012.06.020. Epub 2012 Jul 6.

引用本文的文献

1
A Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy.一种在靶向癌症治疗中具有巨大潜力的小糖分子。
Pharmaceutics. 2023 Mar 11;15(3):913. doi: 10.3390/pharmaceutics15030913.
2
Magnetically Driven Muco-Inert Janus Nanovehicles for Enhanced Mucus Penetration and Cellular Uptake.磁驱动黏液惰性 Janus 纳载体用于增强黏液穿透和细胞摄取。
Molecules. 2022 Oct 27;27(21):7291. doi: 10.3390/molecules27217291.
3
Hydroxyethyl starch based smart nanomedicine.基于羟乙基淀粉的智能纳米药物

本文引用的文献

1
Hybrid nanosystems based on natural polymers as protein carriers for respiratory delivery: Stability and toxicological evaluation.基于天然聚合物的杂交纳米系统作为呼吸递药的蛋白质载体:稳定性和毒理学评价。
Carbohydr Polym. 2015 Jun 5;123:369-80. doi: 10.1016/j.carbpol.2015.01.048. Epub 2015 Feb 3.
2
Biocompatibility of chitosan carriers with application in drug delivery.壳聚糖载体在药物递送中的生物相容性。
J Funct Biomater. 2012 Sep 17;3(3):615-41. doi: 10.3390/jfb3030615.
3
Synthesis and characterization of selenium-chondroitin sulfate nanoparticles.
RSC Adv. 2021 Jan 14;11(6):3226-3240. doi: 10.1039/d0ra09663f.
4
Cellulose Acetate-g-Polycaprolactone Copolymerization Using Diisocyanate Intermediates and the Effect of Polymer Chain Length on Surface, Thermal, and Antibacterial Properties.采用二异氰酸酯中间体的醋酸纤维素-聚己内酯共聚合反应及其对聚合物链长对表面、热学和抗菌性能的影响。
Molecules. 2022 Feb 19;27(4):1408. doi: 10.3390/molecules27041408.
5
Structure and Foaming Properties of Viscous Exopolysaccharides from a Wild Grape-Associated Basidiomycetous Yeast Formerly Known as .一种野生葡萄相关担子菌酵母(以前称为 )来源的粘性胞外多糖的结构和发泡性能。
J Microbiol Biotechnol. 2020 Nov 28;30(11):1739-1749. doi: 10.4014/jmb.2002.02065.
6
Hydrothermal Processing of for the Production of Crude Extracts Used to Formulate Polymeric Nanoparticles.用于制备用于形成聚合物纳米粒子的粗提取物的水热加工。
Mar Drugs. 2020 Jun 27;18(7):336. doi: 10.3390/md18070336.
7
Folate-targeted nanostructured chitosan/chondroitin sulfate complex carriers for enhanced delivery of bortezomib to colorectal cancer cells.叶酸靶向的纳米结构壳聚糖/硫酸软骨素复合载体用于增强硼替佐米向结肠癌细胞的递送
Asian J Pharm Sci. 2019 Jan;14(1):40-51. doi: 10.1016/j.ajps.2018.09.004. Epub 2018 Oct 20.
8
Seaweed Polysaccharide-Based Nanoparticles: Preparation and Applications for Drug Delivery.基于海藻多糖的纳米颗粒:药物递送的制备与应用
Polymers (Basel). 2016 Jan 26;8(2):30. doi: 10.3390/polym8020030.
硒化硫酸软骨素纳米粒子的合成与表征。
Carbohydr Polym. 2012 Sep 1;90(1):122-6. doi: 10.1016/j.carbpol.2012.04.068. Epub 2012 May 8.
4
Chitosan/carrageenan nanoparticles: effect of cross-linking with tripolyphosphate and charge ratios.壳聚糖/卡拉胶纳米粒子:与三聚磷酸钠交联和电荷比的影响。
Carbohydr Polym. 2012 Jun 5;89(1):282-9. doi: 10.1016/j.carbpol.2012.03.010. Epub 2012 Mar 8.
5
Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system.使用纳米颗粒的新型靶向给药:一种开发有效抗利什曼原虫药物递送系统的方法。
Int J Nanomedicine. 2014 Feb 14;9:877-90. doi: 10.2147/IJN.S55678. eCollection 2014.
6
Aggrecan-mimetic, glycosaminoglycan-containing nanoparticles for growth factor stabilization and delivery.模拟聚集蛋白聚糖、含有糖胺聚糖的纳米颗粒,用于生长因子的稳定和递送。
Biomacromolecules. 2014 Feb 10;15(2):680-9. doi: 10.1021/bm401736c. Epub 2014 Jan 24.
7
Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.壳聚糖纳米粒用于 siRNA 递送:优化配方以提高稳定性和效率。
J Control Release. 2014 Feb 28;176:54-63. doi: 10.1016/j.jconrel.2013.12.026. Epub 2013 Dec 31.
8
Oral delivery of therapeutic proteins and peptides: a review on recent developments.口服递送治疗性蛋白质和肽:最新进展综述。
Drug Deliv. 2013 Aug;20(6):237-46. doi: 10.3109/10717544.2013.819611.
9
Pullulan-based nanoparticles as carriers for transmucosal protein delivery.基于支链淀粉的纳米粒作为黏膜下蛋白递药载体。
Eur J Pharm Sci. 2013 Sep 27;50(1):102-13. doi: 10.1016/j.ejps.2013.04.018. Epub 2013 Apr 25.
10
Advances in chitosan-based drug delivery vehicles.壳聚糖基药物传递载体的研究进展。
Nanoscale. 2013 Apr 21;5(8):3103-11. doi: 10.1039/c3nr00338h. Epub 2013 Mar 21.